Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Long-term survival after resection of small hepatocellular carcinoma in patients with preserved liver function

Primary resection and salvage transplantation may be a feasible and rational strategy for patients with small HCC and preserved liver function according to a report in the latest issue of Annals of Surgery.

News image

fiogf49gjkf04

Primary resection, followed by transplantation for recurrence or deterioration of liver function, has recently been suggested as a rational strategy for patients with preserved liver function and hepatocellular carcinomas (HCC) 5 cm or smaller.

However, there are no published data on transplantability after HCC recurrence, or on long-term deterioration of liver function after resection of small HCC in Child-Pugh class A patients. Such data are critical in determining the feasibility of salvage transplantation.

Writing in the March issue of the journal, scientists from the Center for the Study of Liver Disease and Department of Surgery at the University of Hong Kong Medical Center, Hong Kong, China, describe the efforts they took to try and rectify this lack of data.

The research group evaluated the survival results and pattern of recurrence after resection of potentially transplantable small HCC in patients with preserved liver function, with special reference to the implications for a strategy of salvage transplantation.

Using a prospective database, the team examined information on a total of 473 patients who had undergone resection of HCC between 1989 and 1999.

Within the study group, 135 patients aged 65 years or younger, had Child-Pugh class A chronic liver disease (chronic hepatitis or cirrhosis) and transplantable small HCC (solitary 5 cm or two or three tumors 3 cm).

Survival results were analyzed, and the pattern of recurrence was examined for eligibility for salvage transplantation, based on the same criteria as those of primary transplantation for HCC.

Overall survival rates at 1, 3, 5, and 10 years were 90%, 76%, 70%, and 35%, respectively.

The corresponding disease-free survival rates were 74%, 50%, 36%, and 22%.

Cirrhosis and oligonodular tumors were predictive of worse disease-free survival.

Patients with concomitant oligonodular tumors and cirrhosis had a 5-year overall survival rate of 48%, and a disease-free survival rate of 0%, which were significantly worse compared with other subgroups.

Strategy for small HCC with good liver function: resection and later salvage transplantation
Annals of Surgery

At a median follow-up of 48 months, 67 patients had recurrence and 53 (79%) of them were considered eligible for salvage transplantation.

Decompensation from Child-Pugh class A to B or C without recurrence occurred in only 6 patients.

Dr Ronnie Tung-Ping Poon, speaking on behalf of the research group commented "For Child-Pugh class A patients with small HCC, hepatic resection is a reasonable first-line treatment, and is associated with a favorable 5-year overall survival rate."

He continued, "A considerable proportion of patients may survive without recurrence for 5 or even 10 years, and among those with recurrence, the majority may be eligible for salvage transplantation."

"These data suggest that primary resection and salvage transplantation may be a feasible and rational strategy for patients with small HCC and preserved liver function."

"However, primary transplantation may be a preferable option for the subset of patients with oligonodular tumors in cirrhotic liver, in view of the poor survival results after resection", he concluded.

Ann Surg 2002; 235(3): 373-382
11 March 2002

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us